{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:58:20Z","timestamp":1792857500354,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T00:00:00Z","timestamp":1734393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T00:00:00Z","timestamp":1734393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["495901503"],"award-info":[{"award-number":["495901503"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["495901503"],"award-info":[{"award-number":["495901503"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Universit\u00e4tsklinikum Hamburg-Eppendorf (UKE)"},{"name":"Universit\u00e4tsklinikum Hamburg-Eppendorf (UKE)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Tobacco smoking is a relevant determinant of multiple sclerosis (MS) onset, and smokers have increased risk for faster progression of MS compared to non-smokers. While the smoking prevalence is high in Germany, no smoking cessation programs have been developed specifically in MS populations to date, and only little is known about the motivators and barriers influencing smoking cessation in people with MS (pwMS) in Germany. This study aims to identify these factors to inform the design of a tailored smoking cessation intervention.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>As part of a larger program of work, we conducted semi-structured interviews in people with MS (pwMS) to explore their needs, motivators and barriers regarding smoking cessation. We recruited via MS-websites and the email-newsletter of our institution at the University Medical Centre Hamburg-Eppendorf. Participants were eligible if they had a self-reported MS-diagnosis and currently smoked or quit smoking within the last two years but after their MS-diagnosis. Interviews were conducted online and via telephone during May and June 2023. Data were analysed using thematic analysis based on a realistic approach.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Eight women and seven men participated in our interviews. Eleven were current, four were former smokers. Median time since diagnosis was 4 years (range: 1\u201326). Interviews identified MS-diagnosis, concerns about general health, and social factors as relevant motivators to stop smoking. Furthermore, worries about negative consequences when quitting (e.g. fear of missing out on social interactions or weight gain) were identified as a great barrier to smoking cessation. Knowledge about the connection between MS and smoking, and satisfaction with communication with MS clinicians were low. PwMS expressed a need for better conversations with neurologists and expert-led smoking cessation interventions. Additionally, we found that the wish for peer-exchange and the willingness to participate in smoking cessation programs was high.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our results confirm findings of previous studies from other countries, identifying lack of knowledge, unsatisfactory communication with MS clinicians, and worries about negative consequences when quitting as barriers, and the MS-diagnosis as a motivator for smoking cessation. In a next step, we will use our findings for the development of an MS-specific online smoking cessation program.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12889-024-20998-5","type":"journal-article","created":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T14:50:02Z","timestamp":1734447002000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Motivators and barriers for smoking cessation in people with multiple sclerosis: a qualitative study to inform the design of a tailored intervention"],"prefix":"10.1186","volume":"24","author":[{"given":"Alex M.","family":"Keller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"von Glasenapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Kotz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia H.","family":"Marck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Heesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Riemann-Lorenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,17]]},"reference":[{"key":"20998_CR1","doi-asserted-by":"crossref","unstructured":"Olsson T, Barcellos L, Alfredsson L. Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis. Nat Reviews Neurol. 2016;13:25\u201336.","DOI":"10.1038\/nrneurol.2016.187"},{"key":"20998_CR2","unstructured":"Hemmer B, Bayas A, Berthele A, Fa\u00dfhauer E, Flachenecker P, Haghikia A. Diagnose und Therapie der Multiplen Sklerose, Neuromyelitis-optica-Spektrum-Erkrankungen und MOG-IgG-assoziierten Erkrankungen, S2k-Leitlinie: Deutsche Gesellschaft f\u00fcr Neurologie; 2023 2023."},{"issue":"15","key":"20998_CR3","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1212\/01.wnl.0000271884.11129.f3","volume":"69","author":"MG Brown","year":"2007","unstructured":"Brown MG, Kirby S, Skedgel C, Fisk JD, Murray TJ, Bhan V, et al. How effective are disease-modifying drugs in delaying progression in relapsing-onset MS? Neurology. 2007;69(15):1498\u2013507.","journal-title":"Neurology"},{"issue":"11","key":"20998_CR4","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s11910-019-1002-3","volume":"19","author":"U Dalgas","year":"2019","unstructured":"Dalgas U, Langeskov-Christensen M, Stenager E, Riemenschneider M, Hvid LG. Exercise as Medicine in multiple sclerosis\u2014time for a paradigm shift: preventive, symptomatic, and Disease-modifying aspects and perspectives. Curr Neurol Neurosci Rep. 2019;19(11):88.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"6","key":"20998_CR5","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1093\/advances\/nmaa063","volume":"11","author":"AR Tredinnick","year":"2020","unstructured":"Tredinnick AR, Probst YC. Evaluating the effects of Dietary interventions on Disease progression and symptoms of adults with multiple sclerosis: an Umbrella Review. Adv Nutr. 2020;11(6):1603\u201315.","journal-title":"Adv Nutr"},{"issue":"5","key":"20998_CR6","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1177\/1352458506073501","volume":"13","author":"CH Hawkes","year":"2007","unstructured":"Hawkes CH. Smoking is a risk factor for multiple sclerosis: a metanalysis. Multiple Scler J. 2007;13(5):610\u20135.","journal-title":"Multiple Scler J"},{"key":"20998_CR7","first-page":"135245851880172","volume":"25","author":"A Hedstr\u00f6m","year":"2018","unstructured":"Hedstr\u00f6m A. Smoking and its interaction with genetics in MS etiology. Multiple Scler J. 2018;25:135245851880172.","journal-title":"Multiple Scler J"},{"issue":"3","key":"20998_CR8","doi-asserted-by":"publisher","first-page":"243","DOI":"10.5603\/PJNNS.a2020.0032","volume":"54","author":"P Jasielski","year":"2020","unstructured":"Jasielski P, Pi\u0119del F, Rocka A, Petit V, Rejdak K. Smoking as a risk factor of onset and relapse of multiple sclerosis \u2014 a review. Neurol Neurochir Pol. 2020;54(3):243\u201351.","journal-title":"Neurol Neurochir Pol"},{"issue":"10","key":"20998_CR9","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1093\/brain\/awm198","volume":"130","author":"Y Mikaeloff","year":"2007","unstructured":"Mikaeloff Y, Caridade G, Tardieu M, Suissa S, group obotKs. Parental smoking at home and the risk of childhood-onset multiple sclerosis in children. Brain. 2007;130(10):2589\u201395.","journal-title":"Brain"},{"issue":"4","key":"20998_CR10","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1177\/1352458517690271","volume":"23","author":"S Hempel","year":"2017","unstructured":"Hempel S, Graham GD, Fu N, Estrada E, Chen AY, Miake-Lye I, et al. A systematic review of the effects of modifiable risk factor interventions on the progression of multiple sclerosis. Mult Scler. 2017;23(4):513\u201324.","journal-title":"Mult Scler"},{"issue":"10","key":"20998_CR11","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1136\/jnnp-2013-307187","volume":"85","author":"A Manouchehrinia","year":"2014","unstructured":"Manouchehrinia A, Weston M, Tench CR, Britton J, Constantinescu CS. Tobacco smoking and excess mortality in multiple sclerosis: a cohort study. J Neurol Neurosurg Psychiatry. 2014;85(10):1091\u20135.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"20998_CR12","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1001\/jamaneurol.2015.1788","volume":"72","author":"R Ramanujam","year":"2015","unstructured":"Ramanujam R, Hedstr\u00f6m A-K, Manouchehrinia A, Alfredsson L, Olsson T, Bottai M, et al. Effect of Smoking Cessation on multiple sclerosis prognosis. JAMA Neurol. 2015;72(10):1117\u201323.","journal-title":"JAMA Neurol"},{"issue":"13","key":"20998_CR13","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1177\/1352458516685169","volume":"23","author":"FB Briggs","year":"2017","unstructured":"Briggs FB, Gunzler DD, Ontaneda D, Marrie RA. Smokers with MS have greater decrements in quality of life and disability than non-smokers. Multiple Scler J. 2017;23(13):1772\u201381.","journal-title":"Multiple Scler J"},{"issue":"5","key":"20998_CR14","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1177\/1352458515599073","volume":"22","author":"KA McKay","year":"2016","unstructured":"McKay KA, Tremlett H, Fisk JD, Patten SB, Fiest K, Berrigan L, et al. Adverse health behaviours are associated with depression and anxiety in multiple sclerosis: a prospective multisite study. Multiple Scler J. 2016;22(5):685\u201393.","journal-title":"Multiple Scler J"},{"key":"20998_CR15","doi-asserted-by":"publisher","first-page":"104501","DOI":"10.1016\/j.msard.2023.104501","volume":"70","author":"V Vong","year":"2023","unstructured":"Vong V, Simpson-Yap S, Phaiju S, Davenport RA, Neate SL, Pisano MI et al. The association between tobacco smoking and depression and anxiety in people with multiple sclerosis: a systematic review. Mult Scler Relat Dis. 2023;70:104501.","journal-title":"Mult Scler Relat Dis"},{"issue":"18","key":"20998_CR16","doi-asserted-by":"publisher","first-page":"e1950","DOI":"10.1212\/WNL.0000000000009371","volume":"94","author":"M Cortese","year":"2020","unstructured":"Cortese M, Munger KL, Mart\u00ednez-Lapiscina EH, Barro C, Edan G, Freedman MS, et al. Vitamin D, smoking, EBV, and long-term cognitive performance in MS. Neurology. 2020;94(18):e1950\u201360.","journal-title":"Neurology"},{"issue":"8","key":"20998_CR17","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1177\/1352458513515086","volume":"20","author":"AK Hedstr\u00f6m","year":"2014","unstructured":"Hedstr\u00f6m AK, Alfredsson L, Lundkvist Ryner M, Fogdell-Hahn A, Hillert J, Olsson T. Smokers run increased risk of developing anti-natalizumab antibodies. Mult Scler. 2014;20(8):1081\u20135.","journal-title":"Mult Scler"},{"issue":"4","key":"20998_CR18","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1177\/1352458513498635","volume":"20","author":"AK Hedstr\u00f6m","year":"2014","unstructured":"Hedstr\u00f6m AK, Ryner M, Fink K, Fogdell-Hahn A, Alfredsson L, Olsson T, et al. Smoking and risk of treatment-induced neutralizing antibodies to interferon \u03b2-1a. Multiple Scler J. 2014;20(4):445\u201350.","journal-title":"Multiple Scler J"},{"issue":"7","key":"20998_CR19","doi-asserted-by":"publisher","first-page":"e593","DOI":"10.1212\/WNL.0000000000004949","volume":"90","author":"ER Petersen","year":"2018","unstructured":"Petersen ER, Oturai AB, Koch-Henriksen N, Magyari M, S\u00f8rensen PS, Sellebjerg F, et al. Smoking affects the interferon beta treatment response in multiple sclerosis. Neurology. 2018;90(7):e593\u2013600.","journal-title":"Neurology"},{"issue":"5","key":"20998_CR20","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/ntr\/ntx084","volume":"20","author":"R Tanasescu","year":"2018","unstructured":"Tanasescu R, Constantinescu CS, Tench CR, Manouchehrinia A. Smoking Cessation and the reduction of disability progression in multiple sclerosis: a Cohort Study. Nicotine Tob Res. 2018;20(5):589\u201395.","journal-title":"Nicotine Tob Res"},{"issue":"8","key":"20998_CR21","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1136\/jnnp-2022-330848","volume":"94","author":"J Wu","year":"2023","unstructured":"Wu J, Olsson T, Hillert J, Alfredsson L, Hedstr\u00f6m AK. Influence of oral tobacco versus smoking on multiple sclerosis disease activity and progression. J Neurol Neurosurg Psychiatry. 2023;94(8):589\u201396.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"20998_CR22","unstructured":"DEBRA. Deutsche Befragung zum Rauchverhalten. 2023. 2023."},{"key":"20998_CR23","doi-asserted-by":"crossref","unstructured":"Goldin K, Riemann-Lorenz K, Daubmann A, P\u00f6ttgen J, Heesen C. Health behaviors of people with multiple sclerosis and its associations with MS related outcomes: a German clinical cohort. Front Neurol. 2023;14:1172419.","DOI":"10.3389\/fneur.2023.1172419"},{"key":"20998_CR24","doi-asserted-by":"publisher","first-page":"105043","DOI":"10.1016\/j.msard.2023.105043","volume":"79","author":"N Krause","year":"2023","unstructured":"Krause N, Derad C, von Glasenapp B, Riemann-Lorenz K, Temmes H, van de Loo M, et al. Association of health behaviour and clinical manifestation in early multiple sclerosis in Germany \u2013 Baseline characteristics of the POWER@MS1 randomised controlled trial. Multiple Scler Relat Disorders. 2023;79:105043.","journal-title":"Multiple Scler Relat Disorders"},{"key":"20998_CR25","doi-asserted-by":"crossref","unstructured":"Manouchehrinia A, Huang J, Hillert J, Alfredsson L, Olsson T, Kockum I et al. Smoking attributable risk in multiple sclerosis. Front Immunol. 2022;13:840158.","DOI":"10.3389\/fimmu.2022.840158"},{"issue":"7","key":"20998_CR26","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1093\/brain\/awt139","volume":"136","author":"A Manouchehrinia","year":"2013","unstructured":"Manouchehrinia A, Tench CR, Maxted J, Bibani RH, Britton J, Constantinescu CS. Tobacco smoking and disability progression in multiple sclerosis: United Kingdom cohort study. Brain. 2013;136(7):2298\u2013304.","journal-title":"Brain"},{"key":"20998_CR27","doi-asserted-by":"crossref","unstructured":"Polick CS, Rubenstein D, Shah S, Beckham JC, Calhoun PS, Noonan D. Addressing smoking in persons with multiple sclerosis: state of the Science and need for a targeted intervention. Nicotine Tob Res. 2024;26(2):250\u20132.","DOI":"10.1093\/ntr\/ntad159"},{"issue":"3","key":"20998_CR28","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1177\/1352458519858730","volume":"26","author":"CH Marck","year":"2020","unstructured":"Marck CH, Das Nair R, Grech LB, Borland R, Constantinescu CS. Modifiable risk factors for poor health outcomes in multiple sclerosis: the urgent need for research to maximise smoking cessation success. Multiple Scler J. 2020;26(3):266\u201371.","journal-title":"Multiple Scler J"},{"key":"20998_CR29","doi-asserted-by":"publisher","first-page":"103085","DOI":"10.1016\/j.msard.2021.103085","volume":"54","author":"A Hunter","year":"2021","unstructured":"Hunter A, Grech LB, Borland R, Das Nair R, White SL, Marck CH. Barriers and motivators for tobacco smoking cessation in people with multiple sclerosis. Multiple Scler Relat Disorders. 2021;54:103085.","journal-title":"Multiple Scler Relat Disorders"},{"key":"20998_CR30","volume-title":"Welfare. National Drug Strategy Household Survey 2022\u20132023","author":"Health","year":"2024","unstructured":"Health, AIo. Welfare. National Drug Strategy Household Survey 2022\u20132023. AIHW Canberra; 2024."},{"key":"20998_CR31","doi-asserted-by":"crossref","unstructured":"West R, Michie S. A brief introduction to the COM-B model of behaviour and the PRIME theory of motivation. Qeios. 2020.","DOI":"10.32388\/WW04E6.2"},{"issue":"6","key":"20998_CR32","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349\u201357.","journal-title":"Int J Qual Health Care"},{"issue":"1","key":"20998_CR33","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1471-2377-13-37","volume":"13","author":"YC Learmonth","year":"2013","unstructured":"Learmonth YC, Motl RW, Sandroff BM, Pula JH, Cadavid D. Validation of patient determined disease steps (PDDS) scale scores in persons with multiple sclerosis. BMC Neurol. 2013;13(1):37.","journal-title":"BMC Neurol"},{"issue":"2","key":"20998_CR34","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qualitative Res Psychol. 2006;3(2):77\u2013101.","journal-title":"Qualitative Res Psychol"},{"key":"20998_CR35","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/978-3-031-20401-2_16","volume-title":"Global handbook of HEalth Promotion Research","author":"SF Jackson","year":"2023","unstructured":"Jackson SF. Using a Realist Approach in qualitative research to analyse connections among context, intervention and outcome. In: Jourdan D, Potvin L, editors. Global handbook of HEalth Promotion Research. Volume 3. Cham: Springer; 2023. pp. 189\u201399."},{"key":"20998_CR36","doi-asserted-by":"publisher","first-page":"103289","DOI":"10.1016\/j.msard.2021.103289","volume":"56","author":"LB Grech","year":"2021","unstructured":"Grech LB, Hunter A, das Nair R, Borland R, Marck CH. Improving smoking cessation support for people with multiple sclerosis: a qualitative analysis of clinicians\u2019 views and current practice. Mult Scler Relat Disord. 2021;56:103289.","journal-title":"Mult Scler Relat Disord"},{"issue":"6","key":"20998_CR37","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1177\/1077800410364740","volume":"16","author":"JA Maxwell","year":"2010","unstructured":"Maxwell JA. Using numbers in qualitative research. Qualitative Inq. 2010;16(6):475\u201382.","journal-title":"Qualitative Inq"},{"issue":"3","key":"20998_CR38","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0899-3289(93)90066-K","volume":"5","author":"MT Halpern","year":"1993","unstructured":"Halpern MT, Warner KE. Motivations for smoking cessation: a comparison of successful quitters and failures. J Subst Abuse. 1993;5(3):247\u201356.","journal-title":"J Subst Abuse"},{"key":"20998_CR39","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.2147\/PPA.S67767","volume":"8","author":"K Buczkowski","year":"2014","unstructured":"Buczkowski K, Marcinowicz L, Czachowski S, Piszczek E. Motivations toward smoking cessation, reasons for relapse, and modes of quitting: results from a qualitative study among former and current smokers. Patient Prefer Adherence. 2014;8:1353.","journal-title":"Patient Prefer Adherence."},{"key":"20998_CR40","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.addbeh.2018.01.016","volume":"80","author":"F El-Khoury Lesueur","year":"2018","unstructured":"El-Khoury Lesueur F, Bolze C, Melchior M. Factors associated with successful vs. unsuccessful smoking cessation: data from a nationally representative study. Addict Behav. 2018;80:110\u20135.","journal-title":"Addict Behav"},{"issue":"2","key":"20998_CR41","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1177\/201010581001900209","volume":"19","author":"V Joshi","year":"2010","unstructured":"Joshi V, Suchin V, Lim J. Smoking Cessation: Barriers, Motivators and the Role of Physicians \u2014 A Survey of Physicians and Patients. Proc Singapore Healthc. 2010;19(2):145\u201353.","journal-title":"Proc Singapore Healthc."},{"issue":"2","key":"20998_CR42","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1093\/fampra\/cmv103","volume":"33","author":"AC Villanti","year":"2016","unstructured":"Villanti AC, Bover Manderski MT, Gundersen DA, Steinberg MB, Delnevo CD. Reasons to quit and barriers to quitting smoking in US young adults. Fam Pract. 2016;33(2):133\u20139.","journal-title":"Fam Pract"},{"key":"20998_CR43","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.addbeh.2015.10.020","volume":"53","author":"M Ussher","year":"2016","unstructured":"Ussher M, Kakar G, Hajek P, West R. Dependence and motivation to stop smoking as predictors of success of a quit attempt among smokers seeking help to quit. Addict Behav. 2016;53:175\u201380.","journal-title":"Addict Behav"},{"issue":"4","key":"20998_CR44","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.addbeh.2008.11.013","volume":"34","author":"X Zhou","year":"2009","unstructured":"Zhou X, Nonnemaker J, Sherrill B, Gilsenan AW, Coste F, West R. Attempts to quit smoking and relapse: factors associated with success or failure from the ATTEMPT cohort study. Addict Behav. 2009;34(4):365\u201373.","journal-title":"Addict Behav"},{"key":"20998_CR45","doi-asserted-by":"publisher","first-page":"e20170080","DOI":"10.1590\/1806-3713\/e20170080","volume":"45","author":"SAV Rocha","year":"2019","unstructured":"Rocha SAV, Hoepers ATC, Fr\u00f6de TS, Steidle LJM, Pizzichini E, Pizzichini MMM. Prevalence of smoking and reasons for continuing to smoke: a population-based study. Jornal Brasileiro De Pneumologia. 2019;45:e20170080.","journal-title":"Jornal Brasileiro De Pneumologia"},{"issue":"5","key":"20998_CR46","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S0306-4603(98)00014-8","volume":"23","author":"B Borrelli","year":"1998","unstructured":"Borrelli B, Mermelstein R. The role of weight concern and self-efficacy in smoking cessation and weight gain among smokers in a clinic-based cessation program. Addict Behav. 1998;23(5):609\u201322.","journal-title":"Addict Behav"},{"key":"20998_CR47","doi-asserted-by":"publisher","first-page":"103085","DOI":"10.1016\/j.msard.2021.103085","volume":"54","author":"A Hunter","year":"2021","unstructured":"Hunter A, Grech LB, Borland R, das Nair R, White SL, Marck CH. Barriers and motivators for tobacco smoking cessation in people with multiple sclerosis. Mult Scler Relat Disord. 2021;54:103085.","journal-title":"Mult Scler Relat Disord"},{"issue":"2","key":"20998_CR48","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1159\/000323953","volume":"36","author":"AK Artemiadis","year":"2011","unstructured":"Artemiadis AK, Anagnostouli MC, Alexopoulos EC. Stress as a risk factor for multiple sclerosis onset or relapse: a systematic review. Neuroepidemiology. 2011;36(2):109\u201320.","journal-title":"Neuroepidemiology"},{"issue":"3","key":"20998_CR49","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1001\/jama.2020.23541","volume":"325","author":"CD Patnode","year":"2021","unstructured":"Patnode CD, Henderson JT, Coppola EL, Melnikow J, Durbin S, Thomas RG. Interventions for Tobacco Cessation in adults, including pregnant persons: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2021;325(3):280\u201398.","journal-title":"JAMA"},{"key":"20998_CR50","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000165","volume-title":"Physician advice for smoking cessation","author":"C Silagy","year":"2001","unstructured":"Silagy C, Stead LF. Physician advice for smoking cessation. Cochrane Database of Systematic Reviews; 2001."},{"issue":"3","key":"20998_CR51","first-page":"00224","volume":"7","author":"S Kastaun","year":"2021","unstructured":"Kastaun S, Viechtbauer W, Leve V, Hildebrandt J, Funke C, Klosterhalfen S et al. Quit attempts and tobacco abstinence in primary care patients: follow-up of a pragmatic, two-arm cluster randomised controlled trial on brief stop-smoking advice \u2013 ABC versus 5As. ERJ Open Res. 2021;7(3):00224.","journal-title":"ERJ Open Res"},{"issue":"6","key":"20998_CR52","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1111\/j.1360-0443.2011.03770.x","volume":"107","author":"P Aveyard","year":"2012","unstructured":"Aveyard P, Begh R, Parsons A, West R. Brief opportunistic smoking cessation interventions: a systematic review and meta-analysis to compare advice to quit and offer of assistance. Addiction. 2012;107(6):1066\u201373.","journal-title":"Addiction"},{"issue":"22","key":"20998_CR53","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1001\/jama.1991.03470220055026","volume":"266","author":"E Frank","year":"1991","unstructured":"Frank E, Winkleby MA, Altman DG, Rockhill B, Fortmann SP. Predictors of Physicians\u2019 Smoking Cessation advice. JAMA. 1991;266(22):3139\u201344.","journal-title":"JAMA"},{"issue":"7","key":"20998_CR54","doi-asserted-by":"publisher","first-page":"e059637","DOI":"10.1136\/bmjopen-2021-059637","volume":"12","author":"I Weld-Blundell","year":"2022","unstructured":"Weld-Blundell I, Grech L, Borland R, White SL, das Nair R, Marck CH. Smoking habits, awareness and support needs for cessation among people with multiple sclerosis in Australia: findings from an online survey. BMJ Open. 2022;12(7):e059637.","journal-title":"BMJ Open"},{"issue":"6","key":"20998_CR55","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/CEJ.0b013e3282f75e48","volume":"17","author":"V Lemmens","year":"2008","unstructured":"Lemmens V, Oenema A, Knut IK, Brug J. Effectiveness of smoking cessation interventions among adults: a systematic review of reviews. Eur J Cancer Prev. 2008;17(6):535.","journal-title":"Eur J Cancer Prev"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-024-20998-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-024-20998-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-024-20998-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T03:01:51Z","timestamp":1734490911000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-024-20998-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,17]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["20998"],"URL":"https:\/\/doi.org\/10.1186\/s12889-024-20998-5","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,17]]},"assertion":[{"value":"19 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The German ethics committee of the Hamburg Chamber of Physicians approved this research project (registration number 2022-100779-BO-ff). Informed consent was obtained from all participants involved in the study, including permission to be audio-recorded.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3402"}}